Aurinia Pharmaceuticals Inc. Made Big Gain
Wed, Jul 28, 2021 at 05:30 PM
Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ) shot up at $14.24, a gain of 23.8%. On Tue, Jul 27, 2021, AUPH:NASDAQ touched a New 2-Week Intraday Low of $10.85. The stock got featured on our News Catalysts scanner on Mon, Jul 26, 2021 at 06:20 AM in the 'EARNINGS' category. From Tue, Jul 13, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, May 28, 2021 at $15 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ)
Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. The Company is engaged in the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis.
Top 10 Gainers:
- FLGC (FLGC:NASDAQ), 63.12%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 61.18%
- BTBT (BTBT:NASDAQ), 35.82%
- Youdao, Inc. (DAO:NYSE), 30.03%
- Support.com, Inc. (SPRT:NASDAQ), 29.62%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- ZME (ZME:NYSE), 26.09%
- Tilray, Inc. (TLRY:NASDAQ), 25.77%
- GOTU (GOTU:NYSE), 25.26%
- Aurinia Pharmaceuticals Inc. (AUPH:NASDAQ), 23.83%